Vericel Corp·4

Feb 13, 4:05 PM ET

MCLAUGHLIN KEVIN F 4

Research Summary

AI-generated summary

Updated

Vericel (VCEL) Director Kevin McLaughlin Exercises Options, Sells Shares

What Happened

  • Kevin F. McLaughlin, a Vericel (VCEL) director, exercised stock options and sold shares on Feb 11, 2026. He exercised 7,000 options with a $2.63 strike (cost $18,410) and an additional 7,000 shares reported as acquired via conversion at $0.00. He sold 7,000 shares in the open market at $34.66 each, for proceeds of $242,620. The sale was effected under a Rule 10b5-1 trading plan.

Key Details

  • Transaction date: 2026-02-11.
  • Option exercise: 7,000 shares at $2.63 (total cost $18,410) and 7,000 shares reported as acquired at $0.00 (derivative).
  • Sale: 7,000 shares at $34.66 — proceeds $242,620.
  • Footnotes: Sale executed under an automatic Rule 10b5-1 plan adopted March 11, 2024 (F1). The options relate to a 5/3/2017 grant covering 17,500 shares that vested in monthly installments (F2).
  • Shares owned after the transactions: not specified in the Form 4 filing.
  • Filing: Form 4 filed 2026-02-13 for the 2026-02-11 transaction (appears timely).

Context

  • Code meanings: M = option exercise/conversion; S = sale. The exercise and sale occurred the same day, which is commonly seen when insiders exercise options and immediately sell shares (often to cover exercise costs or taxes). Sales under a 10b5-1 plan are pre-arranged trading programs and are typically considered routine. Purchases generally carry more informational weight than routine sales; this filing documents an exercised option followed by an executed sale.